Conference
Once-daily insulin glargine requires a significantly lower dose than insulin detemir twice daily to achieve good glycaemic control in patients with type 2 diabetes failing oral therapy
Authors
Swinnen SGH; Dain MP; Aronson R; Roberts D; Davies M; Gerstein HC; Pfeiffer AFH; DeVries JH; Hoekstra JBL; Holleman F
Volume
52
Pagination
pp. S380-S380
Publisher
SPRINGER
Publication Date
September 1, 2009
Name of conference
45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes
Conference place
Vienna, AUSTRIA
Conference start date
September 30, 2009
Conference end date
October 2, 2009
Conference proceedings
DIABETOLOGIA
ISSN
0012-186X